REFERENCES
- Azarkeivan A, Karimi G, Shaiegan M, . Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect). Pediatr Hematol Oncol. 2009;26:195–201.
- Sklavounou-Tsouroutsoglou XX, . Hepatitis B vaccination in children with thalassemia in northern Greece. Biomed Pharmacother. 1989;43:527–530.
- Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepatitis. 2002;9:390–392.
- Bhatti FA, Amin M, Saleem M. Prevalence of antibody to hepatitis C virus in Pakistani thalassaemics by particle agglutination test utilizing C 200 and C 22–3 viral antigen coated particles. J Pakistan Med Assoc. 1995;45:269–271.
- Buxton JA, Kim JH. Hepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections: a review of the evidence and current recommendations. Can J Infect Dis Med Microbiol. 2008;19:197–202.
- Lee SS, Wong KH, Young BW. Children's age affects hepatitis B vaccine response. J Gastroenterol Hepatol. 2003;18:750–751.
- Kabir A, Alavian SM, Kashani AH. Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs. Hum Vaccin. 2008;4:379–383.
- Banatvala JE, Van Damme P. Hepatitis B vaccine—do we need boosters? J Viral Hepatitis. 2003;10:1–6.
- Gabbuti A, . Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine. 2007;25:3129–3132.